Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | AMGN | VRTX | GILD | BMY |
| Company | Intra-Cellular Ther | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 75.60 | 318.49 | 477.20 | 89.45 | 52.68 |
| High | 76.87 | 319.20 | 480.41 | 89.74 | 52.90 |
| Low | 75.25 | 314.88 | 475.05 | 88.45 | 51.82 |
| Last | 75.81 | 316.98 | 477.70 | 89.00 | 51.92 |
| Change | +0.17 | +1.29 | +5.79 | +0.22 | -1.00 |
| % Change | +0.22% | +0.41% | +1.23% | +0.25% | -1.89% |
| Volume | 410,800 | 1,604,600 | 1,019,700 | 5,734,900 | 7,127,400 |
| 20-Day Average Volume | 442,820 | 1,660,990 | 1,018,700 | 4,870,525 | 9,952,675 |
| Previous Close | 75.64 | 315.69 | 471.91 | 88.78 | 52.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 74.60 | 320.23 | 472.50 | 85.89 | 52.89 |
| 20-Day Raw Stochastic | 57.39% | 21.56% | 58.38% | 89.31% | 25.25% |
| 20-Day Relative Strength | 52.47% | 44.88% | 51.56% | 68.87% | 52.82% |
| Weighted Alpha | +43.70 | +17.74 | +29.89 | +25.21 | +6.26 |
| Today's Opinion | 100% Buy | 8% Buy | 40% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 88% Buy | 8% Buy | 24% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 56% Buy | 40% Buy | 24% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.23% since 10/18/24 | -1.45% since 10/18/24 | -1.10% since 10/18/24 | +2.63% since 10/18/24 | -2.44% since 10/18/24 |
| Low | 74.76 on 10/23/24 | 313.63 on 10/24/24 | 464.78 on 10/23/24 | 85.60 on 10/22/24 | 51.82 on 10/25/24 |
| High | 78.47 on 10/21/24 | 321.80 on 10/21/24 | 487.88 on 10/21/24 | 89.74 on 10/25/24 | 53.40 on 10/24/24 |
| 1-Month | |||||
| %Chg | +1.94% since 09/25/24 | +1.32% since 09/25/24 | +3.45% since 09/25/24 | +8.26% since 09/25/24 | +3.94% since 09/25/24 |
| Low | 70.90 on 10/07/24 | 313.37 on 09/26/24 | 447.70 on 10/07/24 | 81.83 on 09/26/24 | 49.72 on 09/26/24 |
| High | 79.46 on 10/18/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 89.74 on 10/25/24 | 54.54 on 10/02/24 |
| 3-Month | |||||
| %Chg | -6.22% since 07/25/24 | -5.18% since 07/25/24 | -2.96% since 07/25/24 | +16.32% since 07/25/24 | +14.69% since 07/25/24 |
| Low | 70.90 on 10/07/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 82.00 on 07/26/24 | 340.89 on 08/01/24 | 510.64 on 08/01/24 | 89.74 on 10/25/24 | 54.54 on 10/02/24 |
| 6-Month | |||||
| %Chg | +5.10% since 04/25/24 | +17.67% since 04/25/24 | +20.12% since 04/25/24 | +36.36% since 04/25/24 | +16.15% since 04/25/24 |
| Low | 64.09 on 05/20/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 82.00 on 07/26/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 89.74 on 10/25/24 | 54.54 on 10/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,003,640 | 170,039,184 | 123,271,928 | 110,880,920 | 105,247,032 |
| Shares Outstanding, K | 105,575 | 536,435 | 258,053 | 1,245,853 | 2,027,100 |
| Annual Sales | 464,370,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -139,670,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 161,390,000 | 8,388,000,000 | 2,645,600,000 | 6,954,000,000 | 12,201,000,000 |
| Last Quarter Net Income | -16,220,000 | 746,000,000 | -3,593,600,000 | 1,614,000,000 | 1,680,000,000 |
| 60-Month Beta | 1.00 | 0.61 | 0.40 | 0.18 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 08/07/24 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 10/30/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | 09/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.97 | 0.00 | 18.89 | 38.63 |